PHARMACIE DE L'ESPLANADE : revenue, balance sheet and financial ratios

PHARMACIE DE L'ESPLANADE is a French company founded 32 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CLAPIERS (34830), this company of category PME shows in 2022 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE L'ESPLANADE (SIREN 393738612)
Indicator 2023 2022 2021 2020
Revenue N/C 1 340 720 € 1 230 030 € N/C
Net income 96 985 € 143 461 € 91 531 € 33 607 €
EBITDA N/C 150 806 € 101 213 € N/C
Net margin N/C 10.7% 7.4% N/C

Revenue and income statement

In 2023, PHARMACIE DE L'ESPLANADE generates positive net income of 97 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2023: 34 k€ -> 97 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

96 985 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 103%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 28%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

102.776%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

28.305%

Solvency indicators evolution
PHARMACIE DE L'ESPLANADE

Sector positioning

Debt ratio
102.78 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Average -16 pts over 3 years

In 2023, the debt ratio of PHARMACIE DE L'ESPLANADE (102.78) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
28.3% 2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Average

In 2023, the financial autonomy of PHARMACIE DE L'ESPLANADE (28.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.75 years 2022
2021
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent -11 pts over 2 years

In 2022, the repayment capacity of PHARMACIE DE L'ESPLANADE (0.75) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DE L'ESPLANADE

Positioning of PHARMACIE DE L'ESPLANADE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE DE L'ESPLANADE is estimated at 1 144 372 € (range 695 947€ - 1 608 730€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
695k€ 1144k€ 1608k€
1 144 372 € Range: 695 947€ - 1 608 730€
NAF 5 année 2023

Valuation method used

Net Income Multiple
96 985 € × 11.8x = 1 144 372 €
Range: 695 947€ - 1 608 731€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE L'ESPLANADE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE L'ESPLANADE

What is the revenue of PHARMACIE DE L'ESPLANADE ?

The revenue of PHARMACIE DE L'ESPLANADE in 2022 is 1.3 M€.

Is PHARMACIE DE L'ESPLANADE profitable?

Yes, PHARMACIE DE L'ESPLANADE generated a net profit of 97 k€ in 2023.

Where is the headquarters of PHARMACIE DE L'ESPLANADE ?

The headquarters of PHARMACIE DE L'ESPLANADE is located in CLAPIERS (34830), in the department Herault.

Where to find the tax return of PHARMACIE DE L'ESPLANADE ?

The tax return of PHARMACIE DE L'ESPLANADE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE L'ESPLANADE operate?

PHARMACIE DE L'ESPLANADE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.